Opinion

How AI and Genomics are merging to transform precision medicine?

Precision medicine has enabled us to deliver customized healthcare by leveraging the interplay between molecul...

22 May, 2025 | Thursday | Views

Medtech

image credit- shutterstock
India’s orthopaedic and cardiac implant sector to touch $5 B by FY28: Report

According to CareEdge Ratings, India’s orthopaedic and cardiac implant sector, including exports, which ...

21 May, 2025 | Wednesday | News

Start-Ups

image credit- shutterstock
Qure.ai unveils new AI-powered co-pilot tool for frontline healthcare workers in LMICs

Leveraging its strength in digital health innovation, Mumbai-based startup Qure.ai has launched a ...

22 May, 2025 | Thursday | News

Inside Magazine

25 Transformative Years of BIOSIMILARS

2025 marks 25 years since India first ventured into the biosimilar space. Over the past quarter century, the country has consistently solidified its position as a global leader in biosimilar approvals, with 135 approvals till January 2025. Initially focused on simpler biologics, the field now includes developing and approving complex monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), a diversified therapeutic focus, and a growing number of innovative players entering the field. As the industry celebrates this silver jubilee, we reflect on the journey that has not only transformed India's biotechnology sector but has also played a pivotal role in making life saving treatments more accessible and affordable worldwide.

For Feedback, please email us at: communications@mmactiv.com

Sign up here to access BioSpectrum India Flip Book.

Sign up here to access BioSpectrum India Flip Book

Videos

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy